Nektar Therapeutics (NKTR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$62.5
Day's range
$69.49

Nektar Therapeutics Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 4.30 M $309.61 M   4,155.15% 21.20%
BVF INC/IL 05/15/2026 2.56 M $184.16 M   64.12% 12.61%
TWO SEAS CAPITAL LP 05/15/2026 1.96 M $140.96 M   162.91% 9.65%
05/15/2026 1.20 M $86.13 M   100.00% 5.90%
TWO SIGMA INVESTMENTS, LP 05/15/2026 930.74 K $66.97 M   96.77% 4.59%
PROSIGHT MANAGEMENT, LP 05/15/2026 735.00 K $52.88 M   32.52% 3.62%
BLACKROCK, INC. 05/13/2026 692.65 K $49.84 M   7.29% 3.41%
MORGAN STANLEY 05/15/2026 659.39 K $47.44 M   16.41% 3.25%
ARMISTICE CAPITAL, LLC 05/15/2026 578.00 K $41.59 M   -3.02% 2.85%
INVESCO LTD. 05/12/2026 567.46 K $40.83 M   21.21% 2.80%
CITADEL ADVISORS LLC 05/15/2026 513.53 K $36.95 M   65.77% 2.53%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 509.55 K $36.66 M   16.17% 2.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 433.00 K $31.15 M   5.46% 2.13%
WOODLINE PARTNERS LP 05/15/2026 415.34 K $29.88 M   299.36% 2.05%
LORD, ABBETT & CO. LLC 05/14/2026 405.08 K $29.15 M   100.00% 2.00%
MILLENNIUM MANAGEMENT LLC 05/15/2026 404.28 K $29.09 M   -10.97% 1.99%
EMERALD ADVISERS, LLC 05/04/2026 394.60 K $28.39 M   2.67% 1.94%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 390.68 K $28.11 M   20.61% 1.92%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 346.80 K $24.96 M   36.34% 1.71%
UBS GROUP AG 05/05/2026 320.17 K $23.04 M   11.34% 1.58%
GREAT POINT PARTNERS LLC 05/15/2026 316.45 K $22.77 M   50.17% 1.56%
VESTAL POINT CAPITAL, LP 05/15/2026 285.00 K $20.51 M   100.00% 1.40%
22NW, LP 05/15/2026 281.12 K $20.23 M   -15.10% 1.39%
PRIMECAP MANAGEMENT CO/CA/ 05/11/2026 279.15 K $20.08 M   -0.36% 1.38%
ORBIMED ADVISORS LLC 05/15/2026 275.00 K $19.79 M   100.00% 1.35%
GILDER GAGNON HOWE & CO LLC 05/15/2026 271.76 K $19.55 M   30.46% 1.34%
NEARWATER CAPITAL MARKETS, LTD 05/15/2026 261.50 K $18.81 M   325.20% 1.29%
EMERALD MUTUAL FUND ADVISERS TRUST 05/04/2026 256.11 K $18.43 M   1.18% 1.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 249.09 K $17.92 M   -35.02% 1.23%
STATE STREET CORP 05/15/2026 244.73 K $17.61 M   25.08% 1.21%
JPMORGAN CHASE & CO 05/13/2026 240.10 K $15.67 M   59.21% 1.18%
BRAIDWELL LP 05/15/2026 222.70 K $16.02 M   100.00% 1.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 221.10 K $15.91 M   -39.32% 1.09%
PATIENT SQUARE CAPITAL LP 05/15/2026 210.00 K $15.11 M   100.00% 1.03%
BRONTE CAPITAL MANAGEMENT PTY LTD. 04/27/2026 202.50 K $14.57 M   100.00% 1.00%
BRONTE CAPITAL MANAGEMENT PTY LTD. 04/27/2026 198.26 K $14.26 M   100.00% 0.98%
QUINN OPPORTUNITY PARTNERS LLC 05/15/2026 179.25 K $12.90 M   108.75% 0.88%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 169.31 K $12.18 M   100.00% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 168.01 K $12.09 M   39.56% 0.83%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 165.18 K $11.88 M   120.24% 0.81%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 161.25 K $11.60 M   123.86% 0.79%
CAPTION MANAGEMENT, LLC 05/15/2026 150.00 K $10.79 M   100.00% 0.74%
MARSHALL WACE, LLP 05/15/2026 140.59 K $10.12 M   485.22% 0.69%
AMERIPRISE FINANCIAL INC 05/15/2026 136.73 K $9.84 M   100.00% 0.67%
GOLDMAN SACHS GROUP INC 05/15/2026 126.94 K $9.13 M   -14.11% 0.63%
05/15/2026 126.40 K $9.09 M   -31.86% 0.62%
SEVEN GRAND MANAGERS, LLC 05/06/2026 125.00 K $8.99 M   100.00% 0.62%
05/15/2026 125.00 K $8.99 M   100.00% 0.62%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 05/12/2026 122.33 K $8.80 M   -34.97% 0.60%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 121.54 K $8.74 M   -42.21% 0.60%

Nektar Therapeutics institutional Ownership - FAQ's

During the previous two years, 344 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:

FMR LLC: 4.3 M

BVF INC/IL: 2.56 M

Two Seas Capital LP: 1.96 M

TWO SIGMA INVESTMENTS, LP: 930,741

Prosight Management, LP: 735,000

BlackRock, Inc.: 692,650

131.55% of Nektar Therapeutics stock is owned by institutional investors.

Institutional investors have bought a total of 90.05 M shares in the last 24 months. This purchase volume represents approximately $6.23 B in transactions.